TrialHelicobacter

Resilience of the Gut Microbiome to Short Proton Pump Inhibitor Therapy With or Without High-Dosage L. reuteri in H. pylori-Infected Adults.

Stefano Bibbò et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.